Corey Kershaw, MD
Dr. Corey Kershaw is a pulmonologist and critical care physician at UT Southwestern Medical Center. He specializes in the diagnosis and treatment of interstitial lung diseases. He has a particular interest in occupational and environmental lung diseases like malignant pleural mesothelioma and asbestos-related lung cancer.[1]
Dr. Kershaw is part of the Interstitial Lung Disease Program at UT Southwestern, and he says that the key to diagnosing their disease is to listen to his patients’ stories and delve into their history to identify which interstitial lung disease they have. He says, “Listening carefully and spending time with our patients helps us figure out why this happened to them, if there is a reason.” He also provides second opinions on diagnoses that elude other doctors who do not have the same level of expertise and experience with occupational exposure and its effects.[1]
Education and Career
Dr. Kershaw earned his medical degree at the McGovern Medical School at UT Health Science Center. He completed an internship and residency in Internal Medicine at the Emory University School of Medicine and remained at Emory to complete a fellowship in Pulmonary Diseases and Critical Care Medicine.[1]
Following his education, Dr. Kershaw served as an Assistant Professor of Medicine in Emory’s Division of Pulmonary, Allergy, and Critical Care Medicine, as well as Medical Director of the Atlanta VA Medical Center’s Medical Intensive Care Unit. At UT Southwestern, he is a member of the Division of Pulmonary and Critical Care Medicine and holds the titles of Professor in the Department of Internal Medicine, Clinical Services Chief for the Division of Pulmonary and Critical Care Medicine, and Medical Director of the Medical Intensive Care Unit and Respiratory Therapy at William P. Clements Jr. University Hospital.[1]
Research
Dr. Kershaw is actively involved in UT Southwestern’s clinical trials program and has a particular interest in interstitial lung diseases and occupational lung diseases like malignant pleural mesothelioma. His recent work includes co-authoring the following articles that have appeared in professional journals:[1]
- The Importance of Imaging in the Assessment of Interstitial Lung Diseases.Michael B Sneider, Corey D Kershaw> ;Journal of Thoracic Imaging. 2023 Nov 1
- Machine learning prediction for COVID-19 disease severity at hospital admission. Ganesh Raman, Bilal Ashraf, Yusuf Kemal Demir, Corey D Kershaw, Sreekanth Cheruku, Murat Atis, Ahsen Atis, Mustafa Atar, Weina Chen, Ibrahim Ibrahim, Taha Bat, Mutlu Mete> ;BMC Medical Informatics and Decision Making. 2023 Mar 7
- Post COVID Interstitial Lung Abnormalities-Incidence and Management.Mark Robertshaw, Corey D Kershaw> ;Current Pulmonology Reports. 2023 Jan 1
- Alcoholic Lung DiseaseKershaw CD, Guidot DM Alcohol Research and Health 2008 31(1) 66-75
- Na/K-ATPase expression is increased in the lungs of alcohol-fed rats.Otis JS, Mitchell PO, Kershaw CD, Joshi PC, Guidot DM Alcoholism: Clinical and Experimental Research 2008 2(4) 699-705
- Alcohol abuse: Weighing the risks of pneumonia and ARDSKershaw CD, Guidot DM Journal of Respiratory Diseases 2006 27(9) 380-392
- Mechanical ventilation exacerbates alveolar macrophage immune dysfunction in the lungs of ethanol-fed ratsKamat P, Slutsky A, Zhang H, Bechara RI, Brown LAS, Garcia RC, Joshi PC, Kershaw CD, Guidot DM Alcoholism: Clinical and Experimental Research 2005 29(8) 1457-1465
